US seniors call for ban on DTC ads

4 June 2006

39 medical, health and seniors' organizations on the USA are urging Congress to stop the advertising of prescription drugs to consumers, say Commercial Alert and the National Women's Health Network. "Prescription drug ads are dishonest and dangerous," said Gary Ruskin, executive director of Commercial Alert, adding: "they hype the benefits and cloak the risks of prescription drugs."

As Robert Schoellhorn, former chairman of Abbott Laboratories warned over two decades ago, "we believe direct advertising to the consumer introduces a very real possibility of causing harm to patients who may respond to advertisements by pressuring physicians to prescribe medications that may not be required." Mr Ruskin added: "we agree. We would add that the possibility of creating another Vioxx (rofecoxib) catastrophe has only grown since then." The groups are now seeking Members of Congress to introduce legislation to stop direct-to-consumer advertising of prescription drugs.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight